Organization

Completed Access to Information Requests

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

Download datasets of the summaries of completed access to information requests.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Follow:

Search Results

Displaying 1 - 10 of 769
  • Request Number: A-2012-01441

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 179

    Request Summary: Documents pertaining to the new Marihuana for Medical Purposes Regulations announced on December 16, 2012.

    Make an informal request for: A-2012-01441 (HC)

  • Request Number: A-2013-00104

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 604

    Request Summary: Information regarding the approval and device recall of the medical device DUROM HIP RESURFACING SYSTEM, License number 68144 by ZIMMER GMBH.

    Make an informal request for: A-2013-00104 (HC)

  • Request Number: A-2015-00765

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 36

    Request Summary: Information regarding CHILDREN'S ADVIL, Drug Identification Number (DIN) 02232297.

    Make an informal request for: A-2015-00765 (HC)

  • Request Number: A-2013-01027

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 372

    Request Summary: Documents regarding the Gardasil vaccine in relation to the following: decision to grant Gardasil Priority Review status, approval, communications between Health Canada (HC) and Merck Frosst Canada Ltd, and communications between HC and United States Food and Drug Administration. (Jan 1, 2005 to Dec 31, 2006).

    Make an informal request for: A-2013-01027 (HC)

  • Request Number: A-2013-01328

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 62

    Request Summary: Documents related to contacting a foreign regulatory authority. (Jan 1, 2008 to Feb 10, 2014).

    Make an informal request for: A-2013-01328 (HC)

  • Request Number: A-2013-01356

    Organization: Health Canada

    Disposition: All disclosed

    Year: 2016

    Month: December

    Number of Pages: 2

    Request Summary: Adverse Reaction Report (AER) for Cipralex (escitalopram). Report numbers: 000480651, 000542339, 000552042, 000556493.

    Make an informal request for: A-2013-01356 (HC)

  • Request Number: A-2013-01437

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 3050

    Request Summary: Correspondence, briefing notes, reports relating to the drug RU-486 (Mifepristone). (Jan 1, 2011 to Mar 10, 2014).

    Make an informal request for: A-2013-01437 (HC)

  • Request Number: A-2014-00130

    Organization: Health Canada

    Disposition: All disclosed

    Year: 2016

    Month: December

    Number of Pages: 5

    Request Summary: Adverse Reaction Reports (AER) for Tecta (pantoprazole magnesium). Report numbers: 000542457, 000545488, 000547014, 000547037, 000548792, 000548946, 000555696, 000558038, 000560094, 000566579, 000567739, 000568475.

    Make an informal request for: A-2014-00130 (HC)

  • Request Number: A-2014-01056

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 20

    Request Summary: Clinical Assessment Package associated with the request for priority review status for PHEBURANE (Sodium phenylbutyrate) by Medunik Canada.

    Make an informal request for: A-2014-01056 (HC)

  • Request Number: A-2014-01338

    Organization: Health Canada

    Disposition: Disclosed in part

    Year: 2016

    Month: December

    Number of Pages: 20

    Request Summary: Letter issued from the Therapeutic Products Directorate to Mylan Pharmaceuticals ULC certifying that the examination of Mylan-Pregabalin (Pregabalin) tablets was complete and the date the DIN (Drug Identification Number) was assigned.

    Make an informal request for: A-2014-01338 (HC)